Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Pens Articles
Popular Pens Articles
Highly Recommended Pens Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Novo Nordisk’s Improved FlexPen® Now Available in the U.S.
This press release is an announcement submitted by Novo Nordisk, and was not written by Diabetes Health.
"Although iInsulin pens are more popular in countries underused outside North Americain the U.S. versus other countries, the continuedbut new innovations we've seen with the FlexPen® may help meet the needs of people living with the challenges of this disease," said Bruce Bode, MD, FACE, of Atlanta Diabetes Associates.people make the switch.
Novo Nordisk has redesigned the FlexPen®, the number one selling pre-filled insulin pen in the world, to not only require less force when pushing the button to inject insulin, but also to clearly identify each type of insulin with prominent color branding. The FlexPen® is available with three Novo Nordisk insulin products: Levemir® (insulin detemir [rDNA origin] injection); NovoLog® (insulin aspart [rDNA origin] injection); and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).
The improved FlexPen® has enhanced color branding, with color-identifiable cartridge holders for each type of insulin. When the cap is removed, the entire portion under the cap is colored (green for Levemir®, orange for NovoLog®, and clear for NovoLog® Mix 70/30). Packaging for both sample and trade products has been redesigned to match the colors of the FlexPen®. The improvements will help patients, HCPs, and pharmacists easily identify their insulin.
Like the original FlexPen®, the improved FlexPen® allows users to set an appropriate dose and does not permit a dose larger than the amount of insulin remaining in the pen. It also allows dose corrections without loss of insulin and provides doses in one-unit increments up to 60 units per injection (each pen contains 300 units in total). The dose scale of the improved FlexPen® automatically returns to zero after each injection to allow visual confirmation of dose delivery. Like the original FlexPen®, once in use the FlexPen® does not require refrigeration (below 86° F) for up to 42 days with Levemir®, for up to 28 days with NovoLog®, and for up to 14 days with NovoLog® Mix 70/30.
"Although insulin pens are underused in the U.S. versus other countries, the continued innovation we've seen with the FlexPen® may help meet the needs of people living with the challenges of this disease," said Bruce Bode, MD, FACE, of Atlanta Diabetes Associates.
The improved FlexPen® is now available nationwide and is covered by more than 90 percent of insurance plans. For more information about FlexPen®, click here. The prescribing information for the FlexPen® is available by contacting Novo Nordisk or visiting novonordisk-us.com.
Categories: Diabetes, Diabetes, Insulin, Novo Nordisk, Pens
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...